Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.

Thoracic cancer - 1 Jul 2020

Taghizadeh Hossein, Zöchbauer-Müller Sabine, Mader Robert M, Müllauer Leonhard, Klikovits Thomas, Bachleitner-Hofmann Thomas, Hoda Mir A, Prager Gerald W

Abstract excerpt

BACKGROUND: Malignant mesothelioma is an aggressive cancer and has a poor prognosis. Here, we analyzed the feasibility, molecular and gender aspects of targeted therapy recommendations for malignant mesothelioma based on the individual molecular tumor profile. METHODS: In this single-center, real-world retrospective analysis of our platform for precision medicine, we evaluated the molecular profiling of malignant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesothelioma, Malignant
Share to Molecular Targeted Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Recurrence, Local

Share to Patient Selection

Share to Peritoneal Neoplasms

Share to Precision Medicine

Share to Sex Characteristics

Share to Survival Rate

Source

Open in PubMed Open full text

Identifiers

PMID: 32438515
DOI: 10.1111/1759-7714.13491
PMCID: PMC7327667

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.PMID 32438515Read ↗

Genomic Landscape of Malignant Mesotheliomas.Semantic proximity Read ↗

Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice.Semantic proximity Read ↗

Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesotheliomaSemantic proximity Read ↗

Mutational Profiling of Driver Tumor Suppressor and Oncogenic Genes in Brazilian Malignant Pleural Mesotheliomas.Semantic proximity Read ↗

Molecular pathogenesis of malignant mesotheliomaSemantic proximity Read ↗

Transcriptomics based prediction of survival and response to therapy in malignant mesotheliomaSemantic proximity Read ↗

Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesotheliomaSemantic proximity Read ↗

Multiple institutions’ research findings using the National Mesothelioma Virtual BankSemantic proximity Read ↗

Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular LandscapeSemantic proximity Read ↗

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions.Semantic proximity Read ↗

Molecular alterations and potential actionable mutations in peritoneal mesothelioma: a scoping review of high-throughput sequencing studies.Semantic proximity Read ↗

Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.